SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys (2022)
Attributed to:
MRC Centre for Environment and Health
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(21)00542-7
Publication URI: http://dx.doi.org/10.1016/s2213-2600(21)00542-7
Type: Journal Article/Review
Parent Publication: The Lancet Respiratory Medicine